Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial

Overview of attention for article published in Respiratory Research, December 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 49,455 followers.

RT @atscommunity: Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled #asthma: the SPIRIT ran…

25 Dec 2021

Reply Repost Favourite

RT @atscommunity: Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled #asthma: the SPIRIT ran…

24 Dec 2021

Reply Repost Favourite

RT @atscommunity: Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled #asthma: the SPIRIT ran…

24 Dec 2021

Reply Repost Favourite

Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled #asthma: the SPIRIT randomised clinical trial: https://t.co/3ZXU9Bjsgw

24 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.